RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TOSI P
Collezione ASL Torino 4

Items : 3

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.

2023
AOU Alessandria
ASL Città di Torino
ASL Torino 4
AO Ordine Mauriziano

Della Porta MG; Santini V; Pasini P; Naldi I; Giordano L; Finelli C; Turrini M; Tosi P; Selleri C; Tanasi I; Sancetta R; Norata M; Frigeni M; Marchetti M; Grimaldi D; Galimberti S; Fianchi L; Ferrara F; Di Veroli A; Di Bona E; Calvisi A; Castelli A; Bono R; Occhini U; Rivoli G; Nicolino B; Molteni A; Guarini A; Genua A; et alii...

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial. in Haematologica / Haematologica. 2020 Jul;105(7):1937-1947. doi: 10.3324/haematol.2019.226407. Epub 2019 Oct 3.

2020
ASL Torino 4

Bringhen S; D'Agostino M; Paris L; Ballanti S; Pescosta N; Spada S; Pezzatti S; Grasso M; Rota-Scalabrini D; De Rosa L; Pavone V; Gazzera G; Aquino S; Poggiu M; Santoro A; Gentile M; Baldini L; Petrucci MT; Tosi P; Marasca R; Cellini C; Palumbo A; Falco P; Hájek R; Boccadoro M; Larocca A;

Increased mouse survival, tumor growth inhibition and decreased immunoreactive p53 after exposure to magnetic fields. in Bioelectromagnetics / Bioelectromagnetics. 2002 Apr;23(3):230-8. doi: 10.1002/bem.10010.

2002
ASL Torino 4

Tofani S; Cintorino M; Barone D; Berardelli M; De Santi MM; Ferrara A; Orlassino R; Ossola P; Rolfo K; Ronchetto F; Tripodi SA; Tosi P;